U.S. Mortgage Finance Stock News

NYSE:CHWY
NYSE:CHWYSpecialty Retail

Chewy Expands Vet Clinics And Buybacks In Bid For Pet Care Scale

Chewy (NYSE:CHWY) is acquiring Modern Animal, a veterinary platform with nearly 30 clinics, to expand its pet health services footprint. The deal will more than double Chewy's clinic presence and introduce additional technology driven service models and recurring revenue streams. Chewy is also increasing its share repurchase authorization by $500 million, signaling management's confidence in the company's direction. For investors tracking NYSE:CHWY, this move comes as the stock trades...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

Assessing SoFi Technologies (SOFI) Valuation After Short Seller Scrutiny And Big Business Banking Launch

SoFi Technologies (SOFI) is back in focus after a short seller report alleging questionable accounting and misstated debt, which the company firmly rejects, while it simultaneously rolls out its SoFi Big Business Banking platform. See our latest analysis for SoFi Technologies. SoFi’s recent short seller controversy and the launch of Big Business Banking come after a sharp 40.8% year to date share price decline and a 40.6% 90 day share price return. However, the 1 year total shareholder return...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

Why Sandisk (SNDK) Is Up 21.4% After Doubling Down On AI-Focused Memory Supply And Partnerships

In recent months, Sandisk has reported strong AI-driven demand for its NAND flash and enterprise SSDs, extended its Kioxia joint venture to 2034, raised NAND prices by more than 10%, and invested about US$1.00 billion for a 3.9% stake in Nanya Technology alongside a multi-year DRAM supply deal. These moves, combined with tight NAND supply, full product allocation well into 2026 and broad analyst optimism, have reinforced Sandisk’s position as a key supplier to AI data centers and...
NYSE:CTVA
NYSE:CTVAChemicals

A Look At Corteva (CTVA) Valuation As Shares Deliver Strong Recent Returns

Corteva triggered article Corteva (CTVA) is back in focus for investors after recent share moves, with the stock up around 9.5% over the past month and about 21.7% over the past 3 months. See our latest analysis for Corteva. That recent 30 day share price return of 9.5% and 90 day gain of 21.7% sit alongside a 1 year total shareholder return of 45.63%. This suggests momentum has been building over both shorter and longer periods. If Corteva’s move has you looking beyond one stock, this can be...
NYSE:SEI
NYSE:SEIEnergy Services

Is Solaris Energy Infrastructure (SEI) Getting Ahead Of Itself After A 261% One Year Surge?

If you are wondering whether Solaris Energy Infrastructure at US$61.01 is priced fairly or getting ahead of itself, the next sections will help you frame that question with hard numbers. The stock has recently recorded returns of 9.3% over 7 days, 12.9% over 30 days, 21.4% year to date and 260.7% over 1 year, with the 3 year return described as very large and the 5 year return also very large. Recent coverage has focused on Solaris Energy Infrastructure as an energy services name that has...
NasdaqGS:NTSK
NasdaqGS:NTSKSoftware

Is Netskope (NTSK) Now Attractive After Steep Share Price Slide And Mixed Valuation Signals

If you are wondering whether Netskope at around US$8.47 is starting to look interesting on price, the key question is how that tag lines up with the underlying business value. The stock has been under pressure recently, with a 7 day return of a 6.6% decline, a 30 day return of a 29.5% decline, and a year to date return of a 49.9% decline. This naturally raises questions about whether sentiment has swung too far or not far enough. Recent news coverage has focused on Netskope as part of...
NasdaqGS:GRAL
NasdaqGS:GRALBiotechs

GRAIL Junction Alliance Aims To Make Galleri A Routine Workflow Test

GRAIL (NasdaqGS:GRAL) has entered a new collaboration with Junction to integrate its Galleri multi cancer early detection test into Junction’s digital health infrastructure. The partnership is designed to broaden access to Galleri across digital health platforms and healthcare organizations by embedding the test into unified clinical and operational workflows. The collaboration focuses on streamlining ordering, results management, and complex workflow handling for both providers and patients...
NYSE:SE
NYSE:SEMultiline Retail

The Bull Case For Sea (SE) Could Change Following Surprising Shopee And SeaMoney Reacceleration - Learn Why

In early April 2026, Sea Limited reported strong Q4 results with revenue rising across Shopee and SeaMoney, reinforcing its position as a leading consumer internet group in Southeast Asia and beyond. The most interesting development is that upbeat analyst assessments of Sea’s path to profitability and market share expansion are increasingly aligning with the company’s recent operating performance. We’ll now examine how this stronger-than-expected quarter, particularly the acceleration in...
NYSE:GDDY
NYSE:GDDYIT

The Bull Case For GoDaddy (GDDY) Could Change Following Its New AI Agentic Web Push – Learn Why

In early April 2026, Cloudflare and GoDaddy announced a partnership to integrate AI Crawl Control into GoDaddy’s hosting platform, while GoDaddy also introduced an upgraded mobile app and enabled LegalZoom to register a cryptographically verifiable AI agent via GoDaddy ANS. Together, these moves position GoDaddy as a key infrastructure provider for the emerging agentic web, giving small businesses more control over how AI systems access and monetize their online content. We’ll now examine...
NYSE:BWXT
NYSE:BWXTAerospace & Defense

A Look At BWX Technologies (BWXT) Valuation As It Pursues New Uranium Enrichment License

BWX Technologies (BWXT) has notified the U.S. Nuclear Regulatory Commission of plans to seek a uranium enrichment license for a new Erwin, Tennessee facility, which is directly tied to its $1.5b NNSA defense fuels contract. See our latest analysis for BWX Technologies. The uranium enrichment plan comes as BWX Technologies’ share price has climbed to US$230.29, with a 30 day share price return of 17.55% and a 1 year total shareholder return of 129.46%. This suggests momentum has been building...
NYSE:SPG
NYSE:SPGRetail REITs

Assessing Simon Property Group’s Valuation As Eli Simon Takes Over As CEO

Why Eli Simon’s CEO appointment is in focus for Simon Property Group (SPG) The appointment of Eli Simon as CEO after the passing of David Simon has become a key focus for Simon Property Group (SPG), as recent stock gains reflect investor attention on leadership continuity. See our latest analysis for Simon Property Group. Recent trading has been strong, with the share price at US$198.97, a 1 day share price return of 2.54% and a 7 day share price return of 5.46%. The 1 year total shareholder...
NYSE:DHR
NYSE:DHRLife Sciences

How Evercore’s Target Cut And Masimo Deal Debate At Danaher (DHR) Has Changed Its Investment Story

In early April 2026, Evercore ISI reaffirmed its positive view on Danaher while trimming its price target, as investors focused on the company’s upcoming Q1 2026 earnings and ongoing integration of the Masimo acquisition announced in February. Beyond analyst opinions, Danaher’s recent trading has been shaped by stronger sentiment across medical technology and life science tools, with sector momentum amplifying attention on its diagnostics expansion through Masimo’s sensor and AI-enabled...
NYSE:GM
NYSE:GMAuto

Is It Time To Reassess General Motors (GM) After Its 77% One Year Surge?

If you are wondering whether General Motors' recent share price puts it on sale or at a premium, the next sections will help you weigh what you are really paying for each dollar of the business. Over the past week the stock returned 5.8%, on a 30 day return of 2.4%, while year to date it sits at a 5.2% decline and the 1 year return stands at 77.2% with a 3 year return of 129.3% and a 5 year return of 36.0%. Recent headlines around General Motors have focused on the company’s position in the...
NasdaqGS:IPGP
NasdaqGS:IPGPElectronic

Is IPG Photonics’ China Outreach and Eased Supply Risks Quietly Reframing IPGP’s Competitive Moat?

IPG Photonics recently presented its laser technologies at the China Glass 2026 conference in Shanghai, underscoring its engagement with key glass and materials-processing customers in China. At the same time, easing U.S.-Iran tensions and the reopening of the Strait of Hormuz have reduced semiconductor supply concerns, indirectly supporting sentiment around IPG Photonics’ role in advanced manufacturing. We’ll now examine how this easing of supply-chain risk could influence IPG Photonics’...
NYSE:FE
NYSE:FEElectric Utilities

A Look At FirstEnergy (FE) Valuation After Expanded Capital Plan And Transmission Joint Venture Approval

Security leadership shift and governance questions around FirstEnergy stock FirstEnergy (FE) is back on investors’ radar after two governance related developments: a new chief security officer with deep homeland security experience and a shareholder proposal to permanently split the CEO and chair roles. These moves, alongside an expanded multi year capital plan, give you several angles to consider, from operational resilience and cyber risk oversight to board structure and how future projects...
OTCPK:FNMA
OTCPK:FNMADiversified Financial

A Look At Fannie Mae (OTCPK:FNMA) Valuation As Crypto Backed Mortgages Draw Fresh Market Attention

Federal National Mortgage Association (FNMA) has drawn fresh scrutiny after announcing plans to accept crypto backed mortgages. The move directly links Bitcoin funded home loans with its traditional residential finance platform and raises new questions about risk, collateral quality, and investor perception. See our latest analysis for Federal National Mortgage Association. The announcement lands at a time when momentum around Federal National Mortgage Association has been mixed, with a sharp...
NYSE:MDT
NYSE:MDTMedical Equipment

Medtronic And GE HealthCare Tie Imaging Push To Neurosurgery Growth Potential

Medtronic (NYSE:MDT) and GE HealthCare have launched an integrated, real-time cranial surgical imaging platform that connects Stealth AXiS navigation with bkActiv intraoperative ultrasound. The system combines live ultrasound with pre-operative MRI and CT data, supported by AI tools, to support neurosurgeons during complex cranial procedures. The platform is scheduled to debut at the 2026 AANS Scientific Meeting, with features including specialized algorithms, color Doppler, remote controls,...
NYSE:AKR
NYSE:AKRRetail REITs

Is It Too Late To Consider Acadia Realty Trust (AKR) After Its Recent Share Price Rebound?

Investors may be wondering whether Acadia Realty Trust is offering good value at its current price, or if the easier gains have already passed. The stock recently closed at US$20.37, with returns of 4.9% over the last week, a 1.6% decline over the last month, a 1.3% decline year to date, 14.3% over the last year, 74.9% over three years, and 23.6% over five years. Recent coverage has focused on Acadia as a retail focused REIT, with ongoing attention on how its portfolio and tenant mix...
NYSE:CRGY
NYSE:CRGYOil and Gas

Is It Time To Reassess Crescent Energy (CRGY) After Its 78.8% One Year Surge?

If you are wondering whether Crescent Energy's current share price reflects its true worth, the recent trading pattern gives you plenty to think about. The stock has seen a 48.6% return year to date and 78.8% over the last year, with a recent 6.9% 30 day move and a 5.9% pullback over the past week that may have shifted how the market views its risk and reward trade off. Recent news coverage has focused on Crescent Energy's position in the US energy sector and how investors are reacting to...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Biogen’s Alloy Antisense Deal Adds New Dimension To Genetic Medicine Bet

Biogen and Alloy Therapeutics have entered a new collaboration to develop multi target antisense oligonucleotide drugs using Alloy’s AntiClastic ASO platform. The partnership focuses on several undisclosed genetic disease targets and marks Biogen’s first announced use of an advanced antisense platform across multiple programs. For investors watching NasdaqGS:BIIB at a share price of $177.11, this move adds a fresh angle to the story. The stock shows mixed medium to long term performance,...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Is It Time To Revisit Zscaler (ZS) After Its Recent Share Price Slide

If you are wondering whether Zscaler's current share price lines up with its underlying worth, this article will walk through what the numbers actually suggest about value. The stock recently closed at US$122.23, with returns of 11.8% decline over 7 days, 20.5% decline over 30 days, 44.6% decline year to date, 38.3% decline over 1 year, 15.9% gain over 3 years and 36.5% decline over 5 years. Taken together, these figures give you a mixed picture of past performance. Recent headlines around...
NasdaqGS:GILD
NasdaqGS:GILDBiotechs

Gilead’s Deal Spree Shifts Pipeline Toward Oncology And Potential Upside

Early 2026, Gilead Sciences (NasdaqGS:GILD) has moved quickly on acquisitions of Arcellx, Ouro Medicines, and Tubulis. The company has also exercised exclusive licensing options with Cartography Biosciences for solid tumor targets and Kymera Therapeutics for a CDK2 molecular glue degrader. These deals expand Gilead's oncology and autoimmune pipelines and reduce reliance on its established HIV and legacy franchises. Gilead Sciences, trading at around $142.09, is drawing fresh attention as...
NYSE:HII
NYSE:HIIAerospace & Defense

Is It Too Late To Consider Huntington Ingalls Industries (HII) After 104% One Year Return?

If you are wondering whether Huntington Ingalls Industries at around US$403 per share still offers value, the starting point is understanding what the current price actually reflects. The stock has posted a 15.3% return year to date, with a 1.7% move over the last week, a 3.4% decline over the last month, and returns of 104.5% over 1 year, 103.5% over 3 years, and 116.1% over 5 years. These moves have kept Huntington Ingalls Industries on the radar for investors tracking Aerospace & Defense...
NasdaqCM:TH
NasdaqCM:THHospitality

Assessing Target Hospitality (TH) Valuation After Major Hyperscaler Data Center Contract And 2026 Guidance Raise

Target Hospitality (TH) is back in focus after securing a multi year contract with a top five hyperscaler for a North Texas data center campus and raising its 2026 earnings guidance in response. See our latest analysis for Target Hospitality. The recent contract win and 2026 guidance update have coincided with sharp price momentum, with a 30 day share price return of 86.72% and a year to date gain of 83.95%, while the 1 year total shareholder return of 121.73% suggests this latest move builds...